Skip to content

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05645146
Enrollment
360
Registered
2022-12-09
Start date
2022-11-29
Completion date
2028-01-01
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, High Grade Cervical Dysplasia, Smoking Cessation

Brief summary

The goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.

Interventions

BEHAVIORALSmoking Cessation treatment delivered by Tobacco Free Florida Quitline

Phone counseling with the state tobacco quitline

DRUGNicotine patch

Participants will be provided with a 12 week supply of nicotine patches

DRUGNicotine Lozenge

Participants will be provided with a 12 week supply of nicotine lozenges

BEHAVIORALMotivation and Problem Solving (MAPS) intervention

MAPS is a phone counseling approach to facilitating smoking cessation among cervical cancer survivors, which uses a combined motivational interviewing and social cognitive theory based approach to smoking cessation. Participants will receive 6 MAPS based counseling calls over 12 months, along with personally-tailored SMS-delivered text based messages delivered to the participants phone over 2 years.

Sponsors

H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER
James and Esther King Biomedical Research Program
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 100 cigarettes or more smoked in participants lifetime * Speaks English * Currently smoke 1 cigarette or more in the past 30 days * History of cervical cancer or high grade cervical dysplasia * Has a working smartphone * Has a valid home address * Reside in Florida at the time of study enrollment

Exclusion criteria

* Receiving behavioral or pharmacological tobacco treatment * Household member enrolled in this study

Design outcomes

Primary

MeasureTime frameDescription
MAPS vs Standard Treatment in facilitating long term smoking abstinenceat 24 monthsThe primary outcome of this study is self-reported, 7 day point prevalence abstinence over time through the 24 month assessment where participants who report no smoking in the previous 7 days at follow-up assessment are considered abstinent. Efficacy of MAPS vs Standard Treatment will be measured by comparing the number of participants in each group who were able to quit smoking and maintain smoking abstinence for 2 years.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJennifer Vidrine, PhD, MS

Moffitt Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026